Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Affymax Inc AFFY

Healthcare Biotechnology
Affymax, Inc. is a biopharmaceutical company. The Company’s product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The Company has a collaboration to develop and commercialize peginesatide with... see more

Recent & Breaking News (GREY:AFFY)

Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Affymax, Inc.

Business Wire February 27, 2013

Finkelstein Thompson LLP Announces Investigation Of Affymax, Inc.

Business Wire February 27, 2013

"Stock Alert" 98.5% Winning Streak Helps Traders Stay Ahead of the Algos

Marketwired February 26, 2013

Free Research Reports on AFFY, BKS, DVAX and ENDP Issued by the Bedford Report

Marketwired February 26, 2013

Squawk Box Stocks Reports On: Zynga, Inc. (NASDAQ: ZNGA), Affymax, Inc. (NYSE: AFFY), 3D Systems Corp. (NYSE: DDD), Dynavax Technologies Corporation. (NASDAQ: DVAX)

Marketwired February 26, 2013

ZNGA Shares Continue to Climb on Gambling Legislation in Nevada

ACCESS Newswire February 25, 2013

Glancy Binkow & Goldberg LLP Announces Investigation of Affymax, Inc.

Business Wire February 25, 2013

Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Affymax, Inc.

Business Wire February 25, 2013

Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Affymax, Inc.

PR Newswire February 25, 2013

Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots of OMONTYS® (peginesatide) Injection

Business Wire February 23, 2013

U.S. Food and Drug Administration Approved 30% More Drugs in 2012

Marketwired February 18, 2013

Free Research Report on Affymax, Inc., DENTSPLY International, Inc., Howard Hughes Corp. (The), Costamare Inc. and VistaPrint NV

Marketwired February 15, 2013

Turn Timing Into Profits With INTC, PFE, NWSA and AFFY

Marketwired February 15, 2013

Affymax to Present at the BIO CEO & Investor Conference

Business Wire February 6, 2013

Affymax Announces Updates to Senior Leadership Team

Business Wire February 1, 2013

New England Journal of Medicine Publishes Pivotal Trial Data for OMONTYS® (peginesatide) Injection for Treatment of Anemia in Adult Chronic Kidney Disease Patients on Hemodialysis

Business Wire January 23, 2013

Affymax to Present at the J.P. Morgan Healthcare Conference

Business Wire January 3, 2013

Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

Marketwired January 3, 2013

Our Pros Knew SWKS, LRCX, AFFY and RVBD Would Be Top Gainers on Wednesday

Marketwired January 3, 2013

Affymax and Takeda Announce Permanent J-Code for OMONTYS® (peginesatide) Injection is in Effect

Business Wire January 3, 2013